HkeyBio New Platform Launch: AIH, PBC, and IgAN Model Matrix Empowers "One Drug, Multiple Screens" in Autoimmune New Drug R&D

Summary

HkeyBio announced the launch of preclinical disease model platforms covering Autoimmune Hepatitis, Primary Biliary Cholangitis, and IgA Nephropathy to support autoimmune drug R&D. The platform integrates standardized rodent models to enable multiple disease screening from single drug candidates.